AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Letrovian 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Vivichem Pharma

Salt Composition

Letrozole (2.5mg)

Overview Letrovian 2.5mg Tablet

Postmenopausal women with breast cancer may find relief with Letrovian 2.5mg tablets. This medication can be a standalone treatment or integrated with surgical or radiation therapies. In advanced breast cancer, it helps prevent metastasis. Letrovian 2.5mg can be administered with or without food, always following your physician's prescribed dosage and duration for optimal results. Dosage varies depending on the specific application, determined by your doctor to manage your symptoms effectively. Continuous use, as directed, is crucial. Common side effects include heightened perspiration, weariness, hot flashes, and elevated cholesterol. Report any concerning or persistent side effects to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or history of osteoporosis. Comprehensive disclosure of all current medications is essential, as interactions may impact Letrovian's efficacy. Notify your doctor if you are pregnant or nursing. Pre-treatment and ongoing blood tests, potentially including vitamin D levels and bone density assessments, may be conducted.

Uses of Letrovian 2.5mg Tablet

Managing breast cancer

Major Benefits of Letrovian 2.5mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the 2.5mg Letrovian tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.

Common Side effects of Letrovian 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letrovian 2.5mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the 2.5mg Letrovian tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent timing is recommended.

How Letrovian 2.5mg Tablet works:

Estrogen production is reduced by Letrovian 2.5mg Tablets, an aromatase inhibitor. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

No adverse reactions are associated with the concurrent ingestion of alcohol and Letrovian 2.5mg tablets.

PregnancyPregnancyUNSAFE

Using Letrovian 2.5mg tablets during pregnancy poses a serious risk. Pregnant women should consult their physician immediately, as research in animals and pregnant humans indicates substantial harm to the fetus.

Breast feedingBreast feedingUNSAFE

Administering Letrovian 2.5mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking a 2.5mg Letrovian tablet might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

The 2.5mg Letrovian tablet presents a safe treatment option for individuals with kidney disease, requiring no dosage modification. Data on its use in patients with end-stage renal disease remains limited. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use 2.5mg Letrovian tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Letrovian 2.5mg Tablet :

Should you forget a Letrovian 2.5mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Letrovian 2.5mg Tablet

LabelValue
Chemical Category Diphenylmethane-based compound
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Letrovian 2.5mg Tablet

Letrovian 2.5mg tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Letrovian 2.5mg tablets are anti-estrogen medications. They work by inhibiting the aromatase enzyme, thus lowering estrogen production. Since estrogen fuels the growth of some breast cancers, called "estrogen-dependent cancers," reducing estrogen levels can help prevent cancer progression.
For advanced breast cancer or cancer that has spread, continue Letrovian 2.5mg Tablet until tumor progression. Following tamoxifen or surgery, take Letrovian 2.5mg Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential treatment of two years of Letrovian 2.5mg Tablet followed by three years of tamoxifen may be used.
Combining irbesartan and Letrovian 2.5mg tablets is permissible, but monitor your blood pressure closely as Letrovian 2.5mg may elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Letrovian 2.5mg tablets may cause cataracts. Report blurred vision or eye irritation to your doctor promptly.
Experiencing hot flashes may indicate a common side effect of Letrovian 2.5mg Tablet, resulting from lowered estrogen levels. These typically lessen as your body adapts to the medication. However, for some, hot flashes may persist throughout treatment, subsiding within months of its completion. If bothersome, consult your doctor for management options.
While rare, serious side effects of Letrovian 2.5mg tablets may include stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Letrovian 2.5mg tablets can reduce bone density (osteoporosis) by lowering estrogen levels. Your doctor may monitor your bone density before, during, and after treatment.
The Letrovian 2.5mg Tablet is approved by the Ministry of Health and Family Welfare only for inducing ovulation in women with anovulatory infertility.
Letrovian 2.5mg Tablet
77